Anderson IMNutt DJDeakin JFW (2008) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines . J Psychopharmacol14: 1 - 54 .
2.
Aronson ROffman HJJoffe RTNaylor CD (1996) Triiodothyronine augmentation in the treatment of refractory depression: a meta-analysis . Arch Gen Psychiatry53: 842 - 848 .
3.
BNF (2008) Joint Formulary Committee. British National Formulary. 55 ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain.
4.
Bschor TLewitzka USasse JAdli MKoberle UBauer M (2003) Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms . Pharmacopsychiatry36(Suppl. 3): S230 - S234 .
5.
Cooper-Kazaz RApter JTCohen RKaragichev LMuhammed-Moussa SGrupper D (2007) Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial . Arch Gen Psychiatry64: 679 - 688 .
6.
Debonnel GSaint-André EHébert Cde Montigny CLavoie NBlier P (2007) Differential physiological effects of a low dose and high doses of venlafaxine in major depression . Int J Neuropsychopharmacol10: 51 - 61 .
7.
Demyttenaere KJaspers L (2008) Bupropion and SSRI-induced side effects . J Psychopharmacol22: 792 - 804 .
8.
Fava MRush AJWisniewski SRNierenberg AAAlpert JEMcGrath PJ (2006) A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report . Am J Psychiatry163: 1161 - 1172 .
9.
Hawley CJGale TMSivakumaran T (2002) How does the threshold score to enter a major depression trial influence the size of the available patient population for study ? J Affect Disord71: 181 - 187 .
10.
Hoehn-Saric RNinan PBlack DWStahl SGreist JHLydiard B (2000) Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders . Arch Gen Psychiatry57: 76 - 82 .
11.
Hollyman JAFreeling PPaykel ESBhat ASedgwick P (1988) Double-blind placebo-controlled trial of amitriptyline among depressed patients in general practice . J R Coll Gen Pract38: 393 - 397 .
12.
Kirsch IDeacon BJHuedo-Medina TBScoboria AMoore TJJohnson BT (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration . PLoS Med5: e45 .
13.
Lagomasino ITDwight-Johnson MSimpson GM (2005) Psychopharmacology: the need for effectiveness trials to inform evidence-based psychiatric practice . Psychiatr Serv56: 649 - 651 .
14.
McGrath PJStewart JWFava MTrivedi MHWisniewski SRNierenberg AA (2006) Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D Report . Am J Psychiatry163: 1531 - 1541 .
15.
Melichar JKHaida ARhodes CReynolds AHNutt DJMalizia AL (2001) Venlafaxine occupation at the noradrenaline reuptake site: in-vivo determination in healthy volunteers . J Psychopharmacol15: 9 - 12 .
16.
Montgomery SABaldwin DSBlier PFineberg NAKasper SLader M (2007) Which antidepressants have demonstrated superior efficacy? A review of the evidence . Int Clin Psych22: 323 - 329 .
17.
National Institute for Clinical Excellence (2007) Depression: management of depression in primary and secondary care (amended). Clinical Guideline 23. London: NICE.
18.
Nierenberg AAFava MTrivedi MHWisniewski SRThase MEMcGrath PJ (2006) A comparison of lithium and T3 augmentation following two failed medication treatments for depression: a STAR*D report . Am J Psychiatry163: 1519 - 1530 .
19.
Nutt DJ (1995) The anxiety factor in depression . J Psychopharm9: 185 - 189 .
20.
Nutt DJ (2005) Death by tricyclic: the real antidepressant scandal ? J Psychopharm19: 123 - 124 .
21.
Nutt DJSharpe M (2008) Uncritical positive regard? Issues in the efficacy and safety of psychotherapy . J Psychopharmacol22: 3 - 6 .
22.
Richelson E (2002) The clinical relevance of antidepressant interaction with neurotransmitter transporters and receptors . Psychopharm Bull36: 133 - 150 .
23.
Roland MTorgerson DJ (1998) Clinical review understanding controlled trials: what are pragmatic trials ? BMJ316: 285 .
24.
Rush AJTrivedi MHIbrahim HMCarmody TJArnow BKlein DN (2003) The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression . Biol Psychiatry54: 573 - 583 .
25.
Rush AJTrivedi MHWisniewski SRStewart JWNierenberg AAThase ME (2006) Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression . N Engl J Med354: 1231 - 1242 .
26.
Schulberg HCKaton WSimon GERush AJ (1998) Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines . Arch Gen Psychiatry55: 1121 - 1127 .
27.
Schulberg HCKaton WJSimon GERush AJ (1999) Best clinical practice: guidelines for managing major depression in primary medical care . J Clin Psychiatry60(Suppl. 7): 19 - 26 .
28.
Stahl SM (2008) Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, second ed.Cambridge: Cambridge University Press , p. 290.
29.
Thase MEFriedman ESBiggs MMWisniewski SRTrivedi MHLuther JF (2007) Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report . Am J Psychiatry164: 739 - 752 .
30.
Trivedi MHFava MWisniewski SRThase MEQuitkin FWarden D (2006a) Medication augmentation after the failure of SSRIs for depression . N Engl J Med354: 1243 - 1252 .
31.
Trivedi MHRush AJWisniewski SRNierenberg AAWarden DRitz L (2006b) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice . Am J Psychiatry163: 28 - 40 .
32.
Tyrer PMethuen C (2007) Rating Scales in Psychiatry. London: RCPsych Publications, p. 7.
33.
Valenstein M (2006) Keeping our eyes on STAR*D . Am J Psychiatry163: 1484 - 1486 .
34.
West M (1936) Klondike Annie.Paramount Pictures .
35.
Wilson SJBailey JERich ASAdrover MPotokar JNutt DJ (2004) Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram . Eur Neuropsychopharmacol14: 367 - 372 .
36.
Wingo APGhaemi SN (2007) STAR*D level IV methodology . Am J Psychiatry164: 681 .